Developing new methods to modify pyridine compounds for drug discovery
A New General Strategy for Pyridine Functionalization via Dearomatized Intermediates
This study is exploring new ways to change a key part of many medicines to help create better and more effective drugs for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Colorado State University NIH-funded |
| Lab location | 1 site (Fort Collins, United States) |
| Project ID | NIH-10988257 on NIH RePORTER |
What this research studies
This research focuses on creating innovative synthetic strategies to modify pyridine heterocycles, which are important components in many FDA-approved drugs. By transforming pyridines into reactive intermediates, the researchers aim to enable new chemical reactions that can enhance drug development. This approach allows for greater control over the chemical modifications, potentially leading to more effective drug candidates. Patients may benefit from improved medications that arise from these advancements in drug design.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would be individuals with conditions that could be treated by new drug candidates derived from pyridine modifications.
Not a fit: Patients who are not affected by conditions treatable with pyridine-based drugs may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective and targeted medications for various health conditions.
How similar studies have performed: Other research has shown success in developing new synthetic methods for drug discovery, indicating that this approach has potential for significant advancements.
Where this research is happening
Fort Collins, United States
- Colorado State University — Fort Collins, United States (Active)
Researchers
- Principal investigator: Mcnally, Andrew — Colorado State University
- Study coordinator: Mcnally, Andrew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.